Dwight H. Owen

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.208Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

An Informatics Bridge to Improve the Design and Efficiency of Phase I Clinical Trials for Anticancer Drug Combinations

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0160

Top 78%

0.104DataRank

Top 78%1 citations

Lai Wei, Shijun Zhang, Lijun Cheng, Aditi Shendre, Williams Carson +5 more

Papers

Driven by 43 papers — median percentile 0. Top paper: “Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial”.

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0800

N/A

3.5DataRank · unranked

140 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel Shao-Weng Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer

Investigational New Drugs(2025)10.1007/s10637-025-01591-y

N/A

0.165DataRank · unranked

2 citations

Ruohan Wu, Lai Wei, Mikhail M. Dikov, Shankar Suman, Po‐Lan Su +17 more

An Informatics Bridge to Improve the Design and Efficiency of Phase I Clinical Trials for Anticancer Drug Combinations

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0160

Top 78%

0.104DataRank

Top 78%1 citations

Lai Wei, Shijun Zhang, Lijun Cheng, Aditi Shendre, Williams Carson +5 more

Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors

Cancer Investigation(2025)10.1080/07357907.2025.2557004

Top 78%

0.104DataRank

Top 78%1 citations

Songzhu Zhao, Mingjia Li, Lai Wei, Marium Husain, Daniel Spakowicz +15 more

Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer

Journal of Geriatric Oncology(2021)10.1016/j.jgo.2021.02.002

N/A

0DataRank · unranked

42 citations

Lai Wei, Madison Grogan, Rebecca Hoyd, John F. P. Bridges, Sandipkumar Patel +12 more

Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2633

N/A

0DataRank · unranked

11 citations

Menglin Xu, Sandipkumar Patel, Andrew Johns, Madison Grogan, Mingjia Li +13 more

Immune checkpoint inhibitor induced hepatitis: Risk factors, outcomes, and impact on survival.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e14525

N/A

0DataRank · unranked

2 citations

Songzhu Zhao, Sandip H. Patel, Andrew Johns, Madison Grogan, Mingjia Li +9 more

Bone modifying agents and skeletal related events in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18593

N/A

0DataRank · unranked

0 citations

Songzhu Zhao, Lai Wei, Abdul Miah, Mingjia Li, Gabrielle Lopez +11 more

Early changes in lymphocyte/monocyte ratio on-treatment as a prognostic marker to predict overall survival in patients with advanced cancer treated with immune checkpoint inhibitors

Research Square(2021)10.21203/rs.3.rs-758097/v1

Top 100%

0DataRank

Top 100%0 citations

Songzhu Zhao, Mingjia Li, Lai Wei, Marium Husain, Daniel Spakowicz +14 more

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy

Clinical Lung Cancer(2022)10.1016/j.cllc.2021.12.010

N/A

0DataRank · unranked

44 citations

Lai Wei, Sandip H. Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li +17 more

Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2022)10.1016/j.jtcvs.2022.10.007

N/A

0DataRank · unranked

41 citations

Alan Nicholas, G. Alexander Patterson, Salama N. Waqar, Eric M. Toloza, Eric B. Haura +24 more

Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival

Journal of Cancer Research and Clinical Oncology(2022)10.1007/s00432-022-04340-3

N/A

0DataRank · unranked

40 citations

Gabriel Tinoco, Songzhu Zhao, Lai Wei, Andrew Johns, Sandip Pravin Patel +14 more

A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1552

N/A

0DataRank · unranked

36 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancer

Expert Review of Anticancer Therapy(2022)10.1080/14737140.2022.2094772

N/A

0DataRank · unranked

14 citations

Joy Tang, Yizhen Guo, Christopher C. Coss, Thomas A. Mace, Jason J. Bischof +4 more

442 Pre-treatment interstitial abnormalities is a risk factor for immune checkpoint inhibitor pneumonitis in patients with lung cancer

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0442

N/A

0DataRank · unranked

0 citations

Maria Riley, Songzhu Zhao, Jessica Zimmer, Matthew Viveiros, Jing Gennie Wang +10 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0DataRank · unranked

186 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad091

N/A

0DataRank · unranked

29 citations

Shankar Suman, Mounika Goruganthu, Elena E. Tchekneva, Shuxiao Guan, Rajeswara Rao Arasada +28 more

Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer

The Oncologist(2023)10.1093/oncolo/oyad097

N/A

0DataRank · unranked

14 citations

Mike Yang, Lai Wei, Madison Grogan, Daniel Spakowicz, Sandipkumar Patel +10 more

Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1683

N/A

0DataRank · unranked

14 citations

Bryan Remaily, Justin Thomas, Kyeongmin Kim, Samuel K. Kulp, Thomas A. Mace +5 more

Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03373-y

N/A

0DataRank · unranked

13 citations

Maria Riley, Songzhu Zhao, Jing Gennie Wang, Vince Esguerra, Mingjia Li +8 more

Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03392-9

N/A

0DataRank · unranked

11 citations

Songzhu Zhao, Gabrielle Lopez, Austin Secor, Parthib Das, Nitya Surya +19 more

Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers

International Journal of Molecular Sciences(2023)10.3390/ijms241310847

N/A

0DataRank · unranked

11 citations

Bowen Dong, Yali Zhang, Hua-Hsin Hsiao, Emily Isenhart, Jianmin Wang +18 more

Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03371-0

N/A

0DataRank · unranked

11 citations

Mike Yang, Lai Wei, Madison Grogan, Sandipkumar Patel, Mingjia Li +9 more

Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers

Preprints.org(2023)10.20944/preprints202305.1657.v1

N/A

0DataRank · unranked

2 citations

Bowen Dong, Yali Zhang, Hua-Hsin Hsiao, Emily Isenhart, Jianmin Wang +18 more

Data from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.c.6530655.v1

N/A

0DataRank · unranked

0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Supplementary Table S2 from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.22481301

Top 100%

0DataRank

Top 100%0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090

N/A

0DataRank · unranked

0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090.v1

N/A

0DataRank · unranked

0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Patterns of weight change and overall survival (OS) during first-line pembrolizumab treatment in patients with non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e21094

N/A

0DataRank · unranked

0 citations

Songzhu Zhao, Kenneth Chian, Hyunwoo Kwon, Nicholas Jones, Adam Khorasanchi +15 more

Utilizing Drug Combo to improve the design of phase 1 trials for anticancer drugs.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1571

N/A

0DataRank · unranked

0 citations

Shijun Zhang, Lai Wei, Dwight H. Owen, Lang Li, Lei Wang

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0DataRank · unranked

165 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012

N/A

0DataRank · unranked

42 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

Role for Artificial Intelligence in the Detection of Immune-Related Adverse Events

Journal of Clinical Oncology(2024)10.1200/jco-24-01570

N/A

0DataRank · unranked

3 citations

Alexa Meara, Dwight H. Owen, Mohamed I. Elsaid

Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis

Cancer Immunology Immunotherapy(2025)10.1007/s00262-024-03902-3

N/A

0DataRank · unranked

6 citations

Songzhu Zhao, Lai Wei, Joshua A. Englert, Sarah P. Cohen, Morgan A. Inks +5 more

Intramuscular CMT‐167 Tumours Produce a Mild Cachexia Phenotype in C57BL/6J Mice

JCSM Communications(2025)10.1002/rco2.117

N/A

0DataRank · unranked

4 citations

Trang T. Vu, Justin Thomas, Kyeongmin Kim, Camille Stanton, Zhiliang Xie +13 more

Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung Cancer

Clinical Lung Cancer(2025)10.1016/j.cllc.2025.07.002

N/A

0DataRank · unranked

0 citations

Philip Young, Songzhu Zhao, Lai Wei, Sandip H. Patel, Mingjia Li +17 more

Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non‐Small‐Cell Lung Cancer Treated With Front‐Line Immunotherapy‐Based Therapies

Cancer Medicine(2025)10.1002/cam4.71058

N/A

0DataRank · unranked

0 citations

Po‐Lan Su, Songzhu Zhao, Grace Cheng, Nicholas Jones, Kenneth Chian +26 more

DrugCombo: an informatics bridge for anticancer drug combination Phase I trial design

Database(2025)10.1093/database/baaf043

Top 100%

0DataRank

Top 100%0 citations

Shijun Zhang, Lai Wei, Yuxi Zhu, Naleef Fareed, Lijun Cheng +8 more

Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02674-w

N/A

0DataRank · unranked

44 citations

Daniel Spakowicz, Songzhu Zhao, Sandip H. Patel, Andrew Johns, Madison Grogan +11 more

Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy

Lung Cancer(2025)10.1016/j.lungcan.2025.108832

N/A

0DataRank · unranked

0 citations

Mingjia Li, Songzhu Zhao, Lai Wei, Evelyn Goodyear, Kevin Ho +16 more

Association Between RBC Antigen Allo-Antibodies and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Treatment for Advanced Cancers

Cancer Management and Research(2020)10.2147/cmar.s264166

N/A

0DataRank · unranked

6 citations

Songzhu Zhao, Lai Wei, Kerry A. Rogers, Gregory A. Otterson, Tzu‐Fei Wang +2 more

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy

Cancers(2021)10.3390/cancers13215318

N/A

0DataRank · unranked

72 citations

Dwight H. Owen, Yiping Yang, Xiaopei Huang, Amy J. Petty

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-03068-2

N/A

0DataRank · unranked

47 citations

Songzhu Zhao, Mingjia Li, Sandip H. Patel, Andrew Johns, Madison Grogan +13 more

Dwight H. Owen

Indexed papers

Top data-sharing exemplar

Papers